These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 37199303)

  • 1. Eliminating Cancer Stem-Like Cells in Oral Cancer by Targeting Elementary Signaling Pathways.
    Joshi J; Patel H; Bhavnagari H; Tarapara B; Pandit A; Shah F
    Crit Rev Oncog; 2022; 27(4):65-82. PubMed ID: 37199303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel therapeutic strategies for targeting liver cancer stem cells.
    Oishi N; Wang XW
    Int J Biol Sci; 2011 Apr; 7(5):517-35. PubMed ID: 21552419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
    Safa AR
    Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting cancer stem cells by using the nanoparticles.
    Hong IS; Jang GB; Lee HY; Nam JS
    Int J Nanomedicine; 2015; 10(Spec Iss):251-60. PubMed ID: 26425092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Roles of Cancer Stem Cells and Therapy Resistance in Colorectal Carcinoma.
    Das PK; Islam F; Lam AK
    Cells; 2020 Jun; 9(6):. PubMed ID: 32503256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLI3 knockdown decreases stemness, cell proliferation and invasion in oral squamous cell carcinoma.
    Rodrigues MFSD; Miguita L; De Andrade NP; Heguedusch D; Rodini CO; Moyses RA; Toporcov TN; Gama RR; Tajara EE; Nunes FD
    Int J Oncol; 2018 Dec; 53(6):2458-2472. PubMed ID: 30272273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer stem cells.
    Yu Z; Pestell TG; Lisanti MP; Pestell RG
    Int J Biochem Cell Biol; 2012 Dec; 44(12):2144-51. PubMed ID: 22981632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of CD44, CD117 and CD133 in identification of cancer stem cells (CSC) in oral squamous cell carcinomas (OSCC).
    Mărgăritescu C; Pirici D; Simionescu C; Stepan A
    Rom J Morphol Embryol; 2011; 52(3 Suppl):985-93. PubMed ID: 22119814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehending the crosstalk between Notch, Wnt and Hedgehog signaling pathways in oral squamous cell carcinoma - clinical implications.
    Patni AP; Harishankar MK; Joseph JP; Sreeshma B; Jayaraj R; Devi A
    Cell Oncol (Dordr); 2021 Jun; 44(3):473-494. PubMed ID: 33704672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detention and Identification of Cancer Stem Cells in Esophageal Squamous Cell Carcinoma.
    Islam F; Gopalan V; Lam AK
    Methods Mol Biol; 2020; 2129():177-191. PubMed ID: 32056178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer.
    Li Z; Wang Y; Zhu Y; Yuan C; Wang D; Zhang W; Qi B; Qiu J; Song X; Ye J; Wu H; Jiang H; Liu L; Zhang Y; Song LN; Yang J; Cheng J
    Mol Oncol; 2015 Jun; 9(6):1091-105. PubMed ID: 25704916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Stem Cells in Oral Squamous Cell Carcinoma: A Narrative Review on Experimental Characteristics and Methodological Challenges.
    Acharya SK; Shai S; Choon YF; Gunardi I; Hartanto FK; Kadir K; Roychoudhury A; Amtha R; Vincent-Chong VK
    Biomedicines; 2024 Sep; 12(9):. PubMed ID: 39335624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A perspective on challenges and opportunities in characterizing oral cancer stem cells.
    Sadasivam S; Subramanian R
    Front Biosci (Landmark Ed); 2020 Mar; 25(6):1011-1021. PubMed ID: 32114422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting cancer stem cells in solid tumors by vitamin D.
    So JY; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():79-85. PubMed ID: 25460302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated expression of JMJD6 is associated with oral carcinogenesis and maintains cancer stemness properties.
    Lee CR; Lee SH; Rigas NK; Kim RH; Kang MK; Park NH; Shin KH
    Carcinogenesis; 2016 Feb; 37(2):119-128. PubMed ID: 26645717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting CD133 in the enhancement of chemosensitivity in oral squamous cell carcinoma-derived side population cancer stem cells.
    Yu CC; Hu FW; Yu CH; Chou MY
    Head Neck; 2016 Apr; 38 Suppl 1():E231-8. PubMed ID: 25545959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on immune-based therapy strategies targeting cancer stem cells.
    Izadpanah A; Mohammadkhani N; Masoudnia M; Ghasemzad M; Saeedian A; Mehdizadeh H; Poorebrahim M; Ebrahimi M
    Cancer Med; 2023 Sep; 12(18):18960-18980. PubMed ID: 37698048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eradicating Cancer Stem Cells: Concepts, Issues, and Challenges.
    Kaur G; Sharma P; Dogra N; Singh S
    Curr Treat Options Oncol; 2018 Mar; 19(4):20. PubMed ID: 29556842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of hydrogels for targeting cancer stem cells in cancer treatment.
    Li F; Li Z; Wei C; Xu L; Liang Y; Yan J; Li Y; He B; Sun C
    Biomed Pharmacother; 2024 Nov; 180():117486. PubMed ID: 39321506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New emerging roles of CD133 in cancer stem cell: Signaling pathway and miRNA regulation.
    Aghajani M; Mansoori B; Mohammadi A; Asadzadeh Z; Baradaran B
    J Cell Physiol; 2019 Dec; 234(12):21642-21661. PubMed ID: 31102292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.